Web1 mrt. 2024 · Marksans Pharma News and Announcements/notices, Live Marksans Pharma corporate announcement on Deals, Bonus, Rights, Stock Splits, Dividends, … WebWe value Marksans Pharma on both the parameters EV/EBITDA (7x FY24E) and PE valuation of 10x of FY24E EPS and maintain our average target price of INR 80 per …
Result Update Marksans Pharma Ltd. June 2024 Input cost
Web10 apr. 2024 · Marksans Pharma Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 3,269.58 Crore) operating in Pharmaceuticals … WebPizosans is a drug for presumptive therapy in critically ill under going cancer therapy Sanmero - Meropenem (500, 1000 mg) (Our Products) This is an antibiotic of choice which has least bacterial resistance, which is used for treating extremely critically ill patients and considered as 'Ultimate' Lifesaver Anticoagulants buchanan laryngectomy protector
MARKSANS PHARMA LTD. - Share Price Ratios BSE/NSE …
WebMarksans Pharma Dividends > Pharmaceuticals > Dividends declared by Marksans Pharma - BSE: 524404, NSE: MARKSANS Be a PRO Markets News Tech/Startups … WebMoneycontrol App is Asia's #1 App for Business & Finance. Track the latest updates on Indian and Global financial markets on your smartphone with the Moneycontrol App. It covers multiple assets from BSE, NSE, MCX and NCDEX exchanges, so you can track Indices (Sensex & Nifty), Stocks, Futures, Options, Mutual Funds, Commodities and … Web186 rijen · 13 apr. 2024 · Marksans Pharma Peer comparison Get Details on Marksans Pharma company competitors, price comparison and stock market performance on … extended path of hurricane ian